All News

Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.

CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.

On January 19, we'll be co-hosting a tweet chat with Oncology Nursing News and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect

A recent study examined the relationship between polycystic ovarian syndrome, long or irregular periods and ovarian cancer risk.

After a bout with cancer, many things change. Quite a few of those things are changes that can never be changed back to the way it used to be. So, how does one go about learning acceptance?

Kim Johnson discusses making better choices in the face of the unknown after cancer.

A large study at the University of Rochester Medical Center’s Wilmot Cancer Institute sought out to get to the root of the causes of cancer-related cognitive impairment and who may be at risk.

A team of researchers at the University of Buffalo investigated the role that patients' stress and anxiety plays in deciding on treatment.

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

Brian J. Czerniecki, M.D., Ph.D., discusses a promising vaccine for certain patients with breast cancer.

While there is a difference between cancer and mundane medical crises, the mundane counts. Try to be holistic. Survive flu season as well as cancer. Practice wellness.

Breast cancer and melanoma survivor who is also a clutter-clearing author shares her tips for cancer and other papers.

From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.

After the approvals of agents in the second-line setting, researchers are now turning to improving the frontline treatment of kidney cancer.

Chemotherapy agents such as docetaxel will remain a crucial part of treating patients with advanced prostate cancer, says William Oh, M.D.

Because I am a lifelong learner and an educator at heart, I always feel the compelling need to share in case someone else out there might benefit from the fires I've walked through.

Michael J. Mauro, M.D., discusses advances in treating myeloproliferative disorders.

Patients' levels of health literacy often correlate to their understanding of clinical trial randomization, which has an effect on enrollment.

A Keytruda was recently granted a priority review to a supplemental biologics license application to treat patients with metastatic or advanced non-small cell lung cancer.

Although now in remission, Ed has agreed with the oncologist, to take two more rounds of chemo in hopes he might not have another relapse.

Accepting feelings of guilt is not only normal, but it's a part of life.

An article recently published in a special issue of CURE focused on lung cancer, “Quitting Smoking Is Possible and Reduces Cancer Risk,” has generated discussion on social media and in our Discussion Forum.

New advancements are quickly advancing the treatment landscape of lung cancer.

Tecentriq (atezolizumab) is being reviewed for the use in additional settings to treat bladder cancer.

Living resolution-free has given me a chance to really think about what matters now and how I want to live.

In the past 30 years or so, there has been a transition in this country for those diagnosed with cancer. Not very long ago, a diagnosis of cancer meant being admitted to the hospital to wait out the final days in a haze of morphine.

Dimosthenis Andreou, M.D., discussed the Euro-EWING99 trial with CURE.

Many patients with cancer do not qualify for clinical trials because of comorbidities or other health problems. However, a recent study found that many of these patients can actually benefit from trials.